UPDATE: Raymond James Downgrades HCA Holdings (HCA) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
HCA Holdings (HCA) PT Lowered to $90 at Jefferies Following 3Q Pre-Announcement
October 19, 2017 8:48 AM EDTJefferies lowered its price target on HCA Holdings (NYSE: HCA) to $90.00 (from $92.00) while maintaining a Buy rating following the company's 3Q pre-announcement. HCA pre-announced Q3 EBITDA of $1.776B vs. $1.97B consensus. EBITDA was dragged down by the hurricanes ($140MM) and a TX Medicaid... More
